Arsenic Trioxide and All-Trans Retinoic Acid Combination Therapy for the Treatment of High-Risk Acute Promyelocytic Leukemia: Results From the APOLLO Trial

The results of the APOLLO trial support the use of ATO and ATRA for the treatment of newly diagnosed patients with high-risk APL.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2025-08-18
DOI
https://doi.org/10.1200/jco-25-00535
Citations
8
Primary Topic
Retinoids in leukemia and cellular processes
Type
article
Field-Weighted Citation Impact
6.45
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Arsenic Trioxide and All-Trans Retinoic Acid Combination Therapy for the Treatment of High-Risk Acute Promyelocytic Leukemia: Results From the APOLLO Trial

Luca Guarnera, Monica Bocchia, Pau Montesinos, Valentina Mancini et al.
8 citations
Journal of Clinical Oncology
Retinoids in leukemia and cellular processes
6.45
article

Arsenic Trioxide and All-Trans Retinoic Acid Combination Therapy for the Treatment of High-Risk Acute Promyelocytic Leukemia: Results From the APOLLO Trial

Luca Guarnera, Monica Bocchia, Pau Montesinos, Valentina Mancini, Maël Heiblig, Christian Thiede, Lionel Adès, Emmanuelle Tavernier, Ana Garrido Diaz, Sven Zukunft, Karsten Spiekermann, Jamilé Frayfer, Gerhard Ehninger, Jordi Esteve, Miguel Á. Sanz, Caroline Bonmati, Sylvain Chantepie, Pierre Péterlin, Giovanni Rossi, Christoph Röllig, Martin Bornhäuser, Erika Borlenghi, Klaus Hans Metzeler, Carsten Müller‐Tidow, Fatiha Chermat, Daniela Heidenreich, Marie‐Pierre Ledoux, Massimo Bernardi, Claudia Dorothea Baldus, Cristina Gil, Wichard Vogel, Alfonso Piciocchi, Dietger Niederwieser, Enrico Crea, Maria Cristina Miggiano, Monia Lunghi, Mariadomenica Divona, Patrizia Zappasodi, Maria Teresa Voso, Madlen Jentzsch, Livia Gorreo Renzulli, Emanuele Ammatuna, Alexander Hamm, Alwin Krämer, Uwe Platzbecker, Céline Berthon, Kathrin Rieger, Hubert Serve, Pauline Ziller-Walter, Maaike Söhne, Matt L. Weier, Pierre Fenaux, Diana Carp, Hartmut Döhner, Susana Vives Polo
article en
8 citations

Abstract

The results of the APOLLO trial support the use of ATO and ATRA for the treatment of newly diagnosed patients with high-risk APL.

Journal of Clinical OncologyVol. 43(29)
Goethe University Frankfurt (DE), University of Rome Tor Vergata (IT), Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT), University Medical Center Groningen (NL), Université Paris Cité (FR), Heidelberg University (DE), Casa Sollievo della Sofferenza (IT), Hospital de Sant Pau (ES), University Hospital Heidelberg (DE), Centre Hospitalier Universitaire de Lille (FR), Hospital Universitari i Politècnic La Fe (ES), Centre Hospitalier Universitaire de Nantes (FR), Humboldt-Universität zu Berlin (DE), Institut de Cancérologie Strasbourg (FR), Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda (IT), Saint Camillus International University of Health and Medical Sciences (IT), AULSS 2 Marca Trevigiana (IT), Centre hospitalier Emile Roux (FR), Centre Hospitalier Régional et Universitaire de Nancy (FR), Hospices Civils de Lyon (FR), Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT), St. Antonius Ziekenhuis (NL), Institute Cancer De La Loire Lucien Neuwirth (FR), Fondazione Gimema Onlus (IT), University Hospital Schleswig-Holstein (DE), Hôpital Lyon Sud (FR), Centre Hospitalier Universitaire de Caen Normandie (FR), University Children's Hospital Tübingen (DE), University Hospital Leipzig (DE), IRCCS Ospedale San Raffaele (IT), Azienda Ospedaliera Universitaria Senese (IT), Hospital General Universitario de Alicante Doctor Balmis (ES), Policlinico Tor Vergata (IT), Hôpital Saint-Louis (FR), Centre hospitalier universitaire d'Orléans (FR), Hospital Universitari de Vic (ES), Policlinico San Matteo Fondazione (IT), Hospital Universitari Germans Trias i Pujol (ES), University Hospital Ulm (DE), University Hospital Carl Gustav Carus (DE), Ludwig-Maximilians-Universität München (DE), University of Lübeck (DE)
Good health and well-being
Openalex Percentile: Top 3%
Retinoids in leukemia and cellular processes
6.45
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.